RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2016; 27(07): 1091-1095
DOI: 10.1055/s-0035-1561317
DOI: 10.1055/s-0035-1561317
letter
Palladium-Catalyzed Direct Arylation of 2,6-Disubstituted Imidazo[2,1-b][1,3,4]thiadiazoles
Weitere Informationen
Publikationsverlauf
Received: 18. November 2015
Accepted after revision: 14. Dezember 2015
Publikationsdatum:
08. Januar 2016 (online)
Abstract
This work reports the original synthesis of trisarylimidazo[2,1-b][1,3,4]thiadiazole derivatives using a C–H arylation process. The scope of the reaction demonstrated the critical importance of the electronic effects of each substituent on the efficiency of the reaction. In addition, a double efficient ‘one-pot’ functionalization at the C-2 and then at the C-5 positions of 2-bromo-6-arylimidazo[2,1-b][1,3,4]thiadiazole derivatives was achieved using a sequential Suzuki–Miyaura–C–H arylation cascade procedure.
Supporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0035-1561317.
- Supporting Information
-
References and Notes
- 1a Kazzouli SE, Koubachi J, Brahmi NE, Guillaumet G. RSC Adv. 2015; 5: 15292
- 1b Fischmeister C, Doucet H. Green Chem. 2011; 13: 741
-
1c Lyons TW, Sanford MS. Chem. Rev. 2010; 110: 1147
- 1d Ackermann L, Vicente R, Kapdi AR. Angew. Chem. Int. Ed. 2009; 48: 9792
- 1e McGlacken GP, Bateman LM. Chem. Soc. Rev. 2009; 38: 2447
- 1f Seregin IV, Gevorgyan V. Chem. Soc. Rev. 2007; 36: 1173
- 1g Alberico D, Scott ME, Lautens M. Chem. Rev. 2007; 107: 174
- 2a Sharma A, Vacchani D, Van der Eycken E. Chem. Eur. J. 2013; 19: 1158
- 2b Joo JM, Guo P, Sames D. J. Org. Chem. 2013; 78: 738
- 2c Kuhl N, Hopkinson MN, Wencel-Delord J, Glorius F. Angew. Chem. Int. Ed. 2012; 51: 10236
- 2d Chen DY.-K, Youn SW. Chem. Eur. J. 2012; 18: 9452
- 2e Joo JM, Touré BB, Sames D. J. Org. Chem. 2010; 75: 4911
- 2f Roger J, Gottumukkala AL, Doucet H. ChemCatChem 2010; 2: 20
- 3a Verrier C, Lassalas P, Théveau L, Quéguiner G, Trécourt F, Marsais F, Hoarau C. Beilstein J. Org. Chem. 2011; 7: 1584
- 3b Bellina F, Rossi R. Tetrahedron 2009; 65: 10269
- 4 Routier S, Peixoto P, Mérour J.-Y, Coudert G, Dias N, Bailly C, Pierré A, Léonce S, Caignard D.-H. J. Med. Chem. 2005; 48: 1401
- 5a Le Meur M, Bourg S, Massip S, Marchivie M, Jarry C, Guillaumet G, Routier S. Eur. J. Org. Chem. 2014; 3704
- 5b Othman RB, Massip S, Marchivie M, Jarry C, Vercouillie J, Chalon S, Guillaumet G, Suzenet F, Routier S. Eur. J. Org. Chem. 2014; 3225
- 6a Khazi IA. M, Gadad AK, Lamani RS, Bhongade BA. Tetrahedron 2011; 67: 3289
- 6b Ferrari S, Morandi F, Motiejunas D, Nerini E, Henrich S, Luciani R, Venturelli A, Lazzari S, Calò S, Gupta S, Hannaert V, Michels PA. M, Wade RC, Costi MP. J. Med. Chem. 2011; 54: 211
- 6c Jung K.-Y, Kim S.-K, Gao Z.-G, Gross AS, Melman N, Jacobson KA, Kim Y.-C. Bioorg. Med. Chem. 2004; 12: 613
- 6d Vachal P, Toth LM. Tetrahedron Lett. 2004; 45: 7157
- 6e Barnish IT, Cross PE, Dickinson RP, Gadsby B, Parry MJ, Randall MJ, Sinclair IW. J. Med. Chem. 1980; 23: 117
- 7 Terzioglu N, Gürsoy A. Eur. J. Med. Chem. 2003; 38: 781
- 8 Kolavi G, Hegde V, Khazi IA, Gadad P. Bioorg. Med. Chem. 2006; 14: 3069
- 9 Gadad AK, Palkar MB, Anand K, Noolvi MN, Boreddy TS, Wagwade J. Bioorg. Med. Chem. 2008; 16: 276
- 10 Copin C, Henry N, Buron F, Routier S. Eur. J. Org. Chem. 2012; 6804
- 11a Théveau L, Querolle O, Dupas G, Hoarau C. Tetrahedron 2013; 69: 4375
- 11b Balcells D, Clot E, Eisenstein O. Chem. Rev. 2010; 110: 749
- 11c Bellina F, Rossi R. Adv. Synth. Catal. 2010; 352: 1223
- 11d Fagnou K. Top. Curr. Chem. 2010; 292: 35
- 11e Bellina F, Cauteruccio S, Rossi R. Curr. Org. Chem. 2008; 12: 774
- 11f Seregin IV, Gevorgyan V. Chem. Soc. Rev. 2007; 36: 1173
- 12a Simmons EM, Hartwig JF. Angew. Chem. Int. Ed. 2012; 51: 3066
- 12b Le Meur M, Bourg S, Massip S, Marchivie M, Jarry C, Guillaumet G, Routier S. Eur. J. Org. Chem. 2014; 3704
- 13 General Procedure A solution of 2,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivative (1.0 equiv), Cs2CO3 (3.0 equiv) and (het)aryl bromide (1.5 equiv) in dry 1,4-dioxane or toluene (3 mL for 80 mg) was degassed by argon bubbling for 15 min. Xantphos (0.2 equiv) and Pd(OAc)2 (0.1 equiv) were then added, and the mixture was heated to 150 °C for 60 min under microwave irradiation. After removing the solvent in vacuo, the crude product was purified by flash chromatography on silica gel.
- 14 2-(4-Methylphenyl)-5-phenyl-6-(4-nitrophenyl)imidazo-[2,1-b][1,3,4]thiadiazole (2) The reaction was carried out as described in general procedure using 1 (80 mg, 0.24 mmol, 1.0 equiv) and bromobenzene (37 μL, 0.36 mmol, 1.5 equiv) in dioxane (3 mL). The crude product was purified by flash chromatography on silica gel (PE–CH2Cl2, 2:8 to 0:1) to afford 2 as a yellow solid (90 mg, 91%). Rf = 0.36 (PE–CH2Cl2, 2:8); mp >260 °C. IR (ATR diamond): ν = 1593, 1505, 1481, 1338, 1324, 1108, 1084, 971, 856, 816, 739, 708, 681 cm–1. 1H NMR (400 MHz, CDCl3): δ = 8.16 (d, J = 8.7 Hz, 2 H, 2 × HAr), 7.83 (d, J = 8.7 Hz, 2 H, 2 × HAr), 7.77 (d, J = 8.1 Hz, 2 H, 2 × HAr), 7.65 (dd, J = 7.6, 1.5 Hz, 2 H, 2 × HAr), 7.56–7.44 (m, 3 H, 3 × HAr), 7.30 (d, J = 8.1 Hz, 2 H, 2 × HAr), 2.46 (s, 3 H, CH3) ppm. 13C NMR (101 MHz, CDCl3): δ = 162.6 (Cq), 146.8 (Cq), 145.3 (Cq), 142.8 (Cq), 141.4 (Cq), 140.0 (Cq), 130.1 (2 × CHAr), 129.6 (2 × CHAr), 129.3 (CHAr), 129.2 (2 × CHAr), 128.5 (Cq), 128.0 (2 × CHAr), 127.5 (Cq), 127.0 (2 × CHAr), 126.0 (Cq), 124.0 (2 × CHAr), 21.8 (CH3) ppm. HRMS (EI-MS): m/z calcd for C23H16N4O2S: 413.10667 [M + H]+; found: 413.10692.